Table 2.
NCCTG 97-24-51 | |||
TB |
CAI
(N = 85) |
Placebo
(N = 91) |
p-Value
(Wilcoxon) |
Mean (SD) | 6.1 (4.4) | 3.9 (5.0) | |
Median (range) | 5.0 (0.0–24.0) | 2.8 (0.0–37.0) | <0.0001 |
A091105 | |||
TB |
Sorafenib
(N = 49) |
Placebo
(N = 36) |
p-Value
(Wilcoxon) |
Mean (SD) | 4.4 (3.2) | 3.1 (3.0) | |
Median (range) | 3.6 (0.7–18.5) | 2.0 (0.0–13.5) | 0.0042 |